메뉴 건너뛰기




Volumn 1, Issue 5, 2002, Pages 413-415

Finding the next Gleevec: FLT3 targeted kinase inhibitor therapy for acute myeloid leukemia

Author keywords

[No Author keywords available]

Indexed keywords

4 [6 METHOXY 7 [3 (1 PIPERIDINYL)PROPOXY] 4 QUINAZOLINYL] 1 PIPERAZINECARBOXYLIC ACID (4 ISOPROPOXYPHENYL)AMIDE; 6 (2,6 DICHLOROPHENYL) 8 METHYL 2 (3 METHYLTHIOANILINO) 8H PYRIDO[2,3 D]PYRIMIDIN 7 ONE; ANTINEOPLASTIC AGENT; BCR ABL PROTEIN; CEP 701; FLT3 LIGAND; IMATINIB; MIDOSTAURIN; PROTEIN TYROSINE KINASE INHIBITOR; SEMAXANIB; SUNITINIB; UNCLASSIFIED DRUG; CD135 ANTIGEN; CELL SURFACE RECEPTOR; ENZYME INHIBITOR; FLT3 PROTEIN, HUMAN; ONCOPROTEIN; PIPERAZINE DERIVATIVE; PROTEIN TYROSINE KINASE; PYRIMIDINE DERIVATIVE;

EID: 0036595322     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(02)00080-6     Document Type: Review
Times cited : (116)

References (28)
  • 10
    • 0037013143 scopus 로고    scopus 로고
    • Huse, M., and Kuriyan, J. (2002). Cell 109, 275-282.
    • (2002) Cell , vol.109 , pp. 275-282
    • Huse, M.1    Kuriyan, J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.